{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:51:55Z","timestamp":1790466715243,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck Investigator Studies Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy And Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI33144"],"award-info":[{"award-number":["R01AI33144"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI127365"],"award-info":[{"award-number":["R01AI127365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI121054"],"award-info":[{"award-number":["R01AI121054"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.030","type":"journal-article","created":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T13:31:38Z","timestamp":1550669498000},"page":"1775-1784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Differential durability of immune responses to measles and mumps following MMR vaccination"],"prefix":"10.1016","volume":"37","author":[{"given":"Richard B.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna G.","family":"Ovsyannikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth R.","family":"Larrabee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-4457","authenticated-orcid":false,"given":"Gregory A.","family":"Poland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.030_b0005","series-title":"Plotkin's vaccines","first-page":"663","article-title":"Mumps vaccines","author":"Rubin","year":"2017"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.030_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4445","article-title":"Molecular biology, pathogenesis and pathology of mumps virus","volume":"235","author":"Rubin","year":"2014","journal-title":"J Pathol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.030_b0015","doi-asserted-by":"crossref","first-page":"e1004791","DOI":"10.1371\/journal.ppat.1004791","article-title":"Remembering mumps","volume":"11","author":"Latner","year":"2015","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.030_b0020","first-page":"38","article-title":"Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children","volume":"16","author":"Rafiei Tabatabaei","year":"2013","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.vaccine.2019.02.030_b0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM196702022760501","article-title":"Live, attenuated mumps-virus vaccine. 3. Clinical and serologic aspects in a field evaluation","volume":"276","author":"Weibel","year":"1967","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2019.02.030_b0030","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0264-410X(95)00098-L","article-title":"Measles, mumps, and rubella antibodies in children 5\u20136 years after immunization: effect of vaccine type and age at vaccination","volume":"13","author":"Boulianne","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.030_b0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/0264-410X(94)00086-3","article-title":"Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines","volume":"13","author":"Miller","year":"1995","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.02.030_b0040","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/588197","article-title":"Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population","volume":"197","author":"Date","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.030_b0045","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/590115","article-title":"Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak","volume":"198","author":"Rubin","year":"2008","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.030_b0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/INF.0000000000001182","article-title":"Emerging mumps infection","volume":"35","author":"Rubin","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.030_b0055","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CVI.00621-13","article-title":"Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic method","volume":"21","author":"Latner","year":"2014","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2019.02.030_b0060","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/1045-1056(90)90009-O","article-title":"Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus","volume":"18","author":"Christenson","year":"1990","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.030_b0065","first-page":"409","article-title":"Detection of postvaccination mumps virus antibody by neutralization test, enzyme-linked immunosorbent assay and sensitive hemagglutination inhibition test","volume":"31","author":"Fedova","year":"1987","journal-title":"J Hyg Epidemiol Microbiol Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.02.030_b0070","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/JCM.30.8.2139-2144.1992","article-title":"Comparison of a neutralization enzyme immunoassay and an enzyme-linked immunosorbent assay for evaluation of immune status of children vaccinated for mumps","volume":"30","author":"Harmsen","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.030_b0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0166-0934(86)90077-7","article-title":"Determination of vaccine-induced and naturally acquired class-specific mumps antibodies by two indirect enzyme-linked immunosorbent assays","volume":"13","author":"Nigro","year":"1986","journal-title":"J Virol Meth"},{"issue":"2","key":"10.1016\/j.vaccine.2019.02.030_b0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-0934(99)00019-1","article-title":"Assay of humoral immunity to mumps virus","volume":"79","author":"Pipkin","year":"1999","journal-title":"J Virol Meth"},{"issue":"1\u20134","key":"10.1016\/j.vaccine.2019.02.030_b0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01319249","article-title":"Immunological relationships between parainfluenza virus type 4 and other paramyxoviruses studied by use of monoclonal antibodies","volume":"116","author":"Komada","year":"1991","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.030_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.59.1.1","article-title":"An Investigation of the Etiology of Mumps","volume":"59","author":"Johnson","year":"1934","journal-title":"J Exper Med"},{"issue":"8","key":"10.1016\/j.vaccine.2019.02.030_b0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2307\/4585189","article-title":"Cultivation of mumps virus in the developing chick embryo and its application to studies of immunity to mumps in man","volume":"60","author":"Habel","year":"1945","journal-title":"Public Health Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.030_b0100","doi-asserted-by":"crossref","first-page":"283","DOI":"10.4049\/jimmunol.54.3.283","article-title":"Attenuation of virulence with retention of antigenicity of mumps virus after passage in the embryonated egg","volume":"54","author":"Enders","year":"1946","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.030_b0105","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3181\/00379727-123-31599","article-title":"Live attenuated mumps virus vaccine. 1. Vaccine development","volume":"123","author":"Buynak","year":"1966","journal-title":"Proc Soc Exp Biol Med"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.030_b0110","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a third dose of MMR vaccine for mumps outbreak control","volume":"377","author":"Cardemil","year":"2017","journal-title":"New Eng J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.030_b0115","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00251-015-0864-z","article-title":"Single nucleotide polymorphisms\/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children","volume":"67","author":"Ovsyannikova","year":"2015","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2019.02.030_b0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-61779-325-7_16","article-title":"Detection of vaccinia virus-specific IFNgamma and IL-10 secretion from human PBMCs and CD8(+) T cells by ELISPOT","volume":"792","author":"Umlauf","year":"2012","journal-title":"Meth Mol Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.030_b0125","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1128\/CVI.00008-08","article-title":"Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles immunity","volume":"15","author":"Haralambieva","year":"2008","journal-title":"Clin Vacc Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.030_b0130","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1128\/JCM.43.9.4847-4851.2005","article-title":"Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays","volume":"43","author":"Mauldin","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.030_b0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.02.030_b0140","doi-asserted-by":"crossref","first-page":"e011680","DOI":"10.1136\/bmjopen-2016-011680","article-title":"Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials","volume":"6","author":"Voysey","year":"2016","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.vaccine.2019.02.030_b0145","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.030_b0150","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.humimm.2013.06.031","article-title":"Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals","volume":"74","author":"Haralambieva","year":"2013","journal-title":"Hum Immunol"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2019.02.030_b0155","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1016\/j.vaccine.2009.01.086","article-title":"Gender effects on humoral immune responses to smallpox vaccine","volume":"27","author":"Kennedy","year":"2009","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2019.02.030_b0160","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.vaccine.2014.01.090","article-title":"Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts","volume":"32","author":"Haralambieva","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.030_b0165","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/JVI.06125-11","article-title":"Recent mumps outbreaks in vaccinated populations: no evidence of immune escape","volume":"86","author":"Rubin","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.02.030_b0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.meegid.2004.02.003","article-title":"The molecular epidemiology of mumps virus","volume":"4","author":"Muhlemann","year":"2004","journal-title":"Infect Genet Evol"},{"issue":"49","key":"10.1016\/j.vaccine.2019.02.030_b0175","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1016\/j.vaccine.2012.09.053","article-title":"Adverse events following a third dose of measles, mumps, and rubella vaccine in a mumps outbreak","volume":"30","author":"Abedi","year":"2012","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2019.02.030_b0180","first-page":"731","article-title":"Mumps outbreak at a university and recommendation for a third dose of measles-mumps-rubella vaccine \u2013 Illinois, 2015\u20132016","volume":"65","author":"Albertson","year":"2016","journal-title":"MMWR"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.030_b0185","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1503\/cmaj.101371","article-title":"An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada","volume":"183","author":"Deeks","year":"2011","journal-title":"CMAJ"},{"issue":"9","key":"10.1016\/j.vaccine.2019.02.030_b0190","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3201\/eid1909.130299","article-title":"Mumps postexposure prophylaxis with a third dose of measles-mumps-rubella vaccine, Orange County, New York, USA","volume":"19","author":"Fiebelkorn","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.030_b0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CDLI.10.1.19-21.2003","article-title":"Effect of multiple freeze-thaw cycles on detection of measles, mumps, and rubella virus antibodies","volume":"10","author":"Pinsky","year":"2003","journal-title":"Clin Diag Lab Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.030_b0200","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4155\/bio.14.96","article-title":"Stability studies of binding and functional anti-vaccine antibodies","volume":"6","author":"Hendriks","year":"2014","journal-title":"Bioanalysis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.02.030_b0205","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4155\/bio.14.97","article-title":"Stability of anti-immunotherapeutic antibodies in frozen human serum samples","volume":"6","author":"Michaut","year":"2014","journal-title":"Bioanalysis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.02.030_b0210","first-page":"33","article-title":"Detection of mumps virus-specific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice","volume":"131","author":"Vandermeulen","year":"2010","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2019.02.030_b0215","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1086\/596207","article-title":"Persistence of mumps antibodies after 2 doses of measles-mumps-rubella vaccine","volume":"199","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:18:35Z","timestamp":1694636315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":43,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19302257"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential durability of immune responses to measles and mumps following MMR vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}